Correction: Neoadjuvant Trials in ER+ Breast Cancer: A Tool for Acceleration of Drug Development and Discovery

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-18-1516
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

The Role of Neoadjuvant Trials in Drug Development for Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2016English

A Drug Discovery Partnership for Personalized Breast Cancer Therapy

2013English

The Molecular Mechanisms Underlying the Pharmacological Actions of ER Modulators: Implications for New Drug Discovery in Breast Cancer

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2010English

Neoadjuvant Palbociclib on ER+ Breast Cancer (N007): Clinical Response and EndoPredict Value

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2018English

Mouse Models of Human Bladder Cancer as a Tool for Drug Discovery

Current Protocols in Pharmacology
MedicinePharmacology
2010English

Advances in Small-Molecule Drug Discovery for Triple-Negative Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2015English

Pcn290 - Use of PCR as a Surrogate Primary Endpoint in Drug Pivotal Trials in Neoadjuvant Early Breast Cancer in Eu: A Perspective From Regulators and Payers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines

PLoS ONE
Multidisciplinary
2012English

Neoadjuvant Chemotherapy in Breast Cancer

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy